H36.819
Nonproliferative sickle-cell retinopathy, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Nonproliferative sickle-cell retinopathy is an eye condition that affects individuals with sickle cell disease. It involves changes in the blood vessels of the retina, the light-sensitive tissue at the back of the eye. This condition is classified under ICD-10 code H36.819 and is characterized by non-proliferative stages, meaning there is no abnormal growth of new blood vessels yet. Recognizing and understanding this condition is essential for monitoring eye health and preventing potential complications that could lead to vision problems or loss.
Causes & Symptoms
Clinical Causes: Sickle cell disease, a hereditary blood disorder that causes the blood cells to be abnormally shaped, leading to blockages in small blood vessels. Vascular damage due to repeated sickling episodes affecting the retinal vessels.
Key Symptoms: Patchy or blurred vision in one or both eyes. Floaters or spots floating in the visual field. Sight changes that may develop gradually over time. No noticeable symptoms in early stages, making regular eye exams important.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves comprehensive eye examinations, including dilated fundus examinations to visualize the retina. Imaging tests like fluorescein angiography can help detect areas of blood vessel damage and leakage. Regular screenings are vital for individuals with sickle cell disease to identify retinal changes early.
Treatment Protocols: While nonproliferative sickle-cell retinopathy may not always require immediate intervention, monitoring is essential. If the condition progresses, treatments may include laser therapy to seal leaking blood vessels, or other ocular procedures to prevent further damage. Managing the underlying sickle cell disease through appropriate medical care can help reduce the risk of retinal complications.
Clinical Advice & FAQs
Billing Guidance
Is H36.819 a billable ICD-10 code?
Yes, H36.819 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.819?
Clinical documentation must specify the nature of Nonproliferative sickle-cell retinopathy, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference